1 Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68, 394-424, doi:10.3322/caac.21492 (2018).
2 Teoh, J. Y. et al. Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita. Eur Urol 78, 893-906, doi:10.1016/j.eururo.2020.09.006 (2020).
3 Krajewski, W. et al. Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis. J Clin Med 10, doi:10.3390/jcm10040651 (2021).
4 Krajewski, W. et al. Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes. World J Urol, doi:10.1007/s00345-020-03522-3 (2020).
5 Sylvester, R. J. et al. European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel. Eur Urol, doi:10.1016/j.eururo.2020.12.033 (2021).
6 Soloway, M. S. & Masters, S. Urothelial susceptibility to tumor cell implantation: influence of cauterization. Cancer 46, 1158-1163, doi:10.1002/1097-0142(19800901)46:5<1158::aid-cncr2820460514>3.0.co;2-e (1980).
7 Sylvester, R. J. et al. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? Eur Urol 69, 231-244, doi:10.1016/j.eururo.2015.05.050 (2016).
8 Pode, D., Alon, Y., Horowitz, A. T., Vlodavsky, I. & Biran, S. The mechanism of human bladder tumor implantation in an in vitro model. J Urol 136, 482-486, doi:10.1016/s0022-5347(17)44926-3 (1986).
9 Fechner, G., Pocha, K., Schmidt, D. & Muller, S. C. Reducing recurrence and costs in superficial bladder cancer: preclinical evaluation of osmotic cytolysis by distilled water vs. mitomycin. Int J Clin Pract 60, 1178-1180, doi:10.1111/j.1742-1241.2006.00847.x (2006).
10 Matsuoka, Y., Taoka, R., Xia, Z., Sugimoto, M. & Kakehi, Y. Hyperthermic therapy using warm sterile water enhances cytocidal effects on bladder cancer cells. Scand J Urol 54, 65-69, doi:10.1080/21681805.2019.1708967 (2020).
11 Sangeda, R. Z. et al. Prevention of tumor cell reimplantation during transurethral resection: the in-vitro antiadhesive and cytotoxic properties of an irrigant containing polyethylene glycol 400. Anticancer Drugs 21, 645-650, doi:10.1097/CAD.0b013e32833a148d (2010).
12 Taoka, R., Williams, S. B., Ho, P. L. & Kamat, A. M. In-vitro cytocidal effect of water on bladder cancer cells: The potential role for intraperitoneal lavage during radical cystectomy. Can Urol Assoc J 9, E109-113, doi:10.5489/cuaj.2435 (2015).
13 Bijalwan, P., Pooleri, G. K. & Thomas, A. Comparison of sterile water irrigation versus intravesical mitomycin C in preventing recurrence of nonmuscle invasive bladder cancer after transurethral resection. Indian J Urol 33, 144-148, doi:10.4103/iju.IJU_371_16 (2017).
14 Roti Roti, J. L. Cellular responses to hyperthermia (40-46 degrees C): cell killing and molecular events. Int J Hyperthermia 24, 3-15, doi:10.1080/02656730701769841 (2008).
15 Rampersaud, E. N., Vujaskovic, Z. & Inman, B. A. Hyperthermia as a treatment for bladder cancer. Oncology (Williston Park) 24, 1149-1155 (2010).
16 van der Heijden, A. G. et al. The effect of hyperthermia on mitomycin-C induced cytotoxicity in four human bladder cancer cell lines. Eur Urol 46, 670-674, doi:10.1016/j.eururo.2004.06.009 (2004).